Skip to main content
. 2021 Apr 22;2021(4):CD013170. doi: 10.1002/14651858.CD013170.pub2

2. Study results grouped by outcome measures and interventions – cough augmentation therapy compared to alternative individual cough augmentation therapies.

Outcome measure Unassisted cough MI ME MI‐E MAC Manual BS Mechanical BS Sham BS GPB Between‐group comparison
PCF
(L/min)
 
 
Chatwin 2003 (n = 22)
Mean (95% CI)
169
(129 to 209)a
182 (
147 to 217)
235
(186 to 284)
297
(246 to 350)
188
(146 to 229)
ME vs unassisted cough: P < 0.01
MI‐E vs unassisted cough: P < 0.001
MI‐E vs ME: P < 0.001
Toussaint 2016 (n = 52)
Mean ± SD baseline to after intervention
125 ± 52 to 186 ± 50; P < 0.001; n = 25 132 ± 55 to 199 ± 48; P = 0.001; n = 27 P = 0.33
Del Amo Castrillo 2019 (n = 20)
Median/IQR
176/68a Data not reported Data not reported P < 0.001 comparing MI to baseline (favouring MI)
P < 0.001 comparing MI to BS (favouring MI)
P = 0.004 comparing BS to baseline (favouring BS)
Torres‐Castro 2016 (n = 14)
MD ± SD (95% CI) baseline to after interventionb
72.86 ± 61.84 (15.67 to 130.05); P = 0.02 32.14 ± 26.44 (7.69 to 56.59); P = 0.018 P = 0.14
Transcutaneous oxygen saturation
(%)
Jenkins 2014 (n = 23)
Mean ± SD before to after intervention
96 ± 3.2 to 96 ± 3 96 ± 3.6 to 96 ± 2.5 NS
Tidal volume (mL) Jenkins 2014 (n = 23)
Mean ± SD before to after intervention
277 ± 131 to 310 ± 148; P < 0.001 303 ± 141 to 289 ± 128; NS Significance levels not reported
Maximum inspiratory or insufflation capacity (L or mL) Toussaint 2016 (n = 52)
mean ± SD, L
1.344 ± 0.520; n = 25 1.481 ± 0.477; n = 27 Mechanical vs manual BS: MD 0.14, 95% CI –0.13 to 0.41; P = 0.3
Del Amo Castrillo 2019 (n = 20)
median (IQR), L
1.630
(1.247 to 1.870)
1.320
(1.085–1.755)
P = 0.12
Torres‐Castro 2016 (n = 14)
MD between baseline vital capacity and postintervention maximum inspiratory capacityb
mean ± SD (95% CI), mL
435.0 ± 364.5
(98.61 to 772.82); P = 0.02
454.29 ± 408.16 (76.80 to 831.77); P = 0.03 MD 19.29, 95% CI –386.09 to 424.67; P = 0.93
Minute ventilation
(L/min)
Jenkins 2014 (n = 23)
Mean ± SD before to after intervention
6.8 ± 3.1 to 8.0 ± 3.5; P < 0.001 7.4 ± 4.9 to 6.9 ± 3.3; NS Significance levels not reported
Maximal expiratory pressure
(cmH2O)
 
Toussaint 2016 (n = 52)
Mean ± SD
26 ± 9 28 ± 10 P = 0.45
Respiratory rate
(breaths/minute)
 
 
Jenkins 2014 (n = 23)
Mean ± SD before to after intervention
27 ± 9.2 to 28 ± 10.6; P < 0.05 26 ± 10.3 to 26 ± 10.4; NS Significance levels not reported
Ability to perform breath stacking
(%)
 
Toussaint 2016 (n = 52)
88 89 P = 0.9
Number of insufflations to maximal insufflation capacity
(n)
Toussaint 2016 (n = 52)
Mean ± SD
1.8 ± 0.6 2.6 ± 0.6 P < 0.001
Comfort, distress, and strength of cough
(VAS 10‐point score)
Chatwin 2003 (n = 22)
Mean (95% CI)
5.4 (4.5 to 6.3)a 5.8 (4.8 to 6.8)
(NS)
6.9 (5.3 to 7.0)
(NS)
7.3 (6.6 to 8.0)
(NS)
5.9 (5.2 to 6.7)
(NS)
Separate VAS scores not presented
Significance levels not reported
Comfort
(VAS 10‐point score)
Del Amo Castrillo 2019 (n = 20)
Median (IQR)
6.4 (5.2 to 7.6) 6.5 (3.9–7.4) P = 0.31
Subjective cough effectiveness (VAS 10‐point score) Del Amo Castrillo 2019 (n = 20)
Median (IQR)
6.0 (4.85 to 8.2) 6.2 (5.1–7.1) P = 0.17

BS: breathstacking; CI: confidence interval; GPB: glossopharyngeal breathing; IQR: interquartile range; PCF: peak cough flow; MAC: manually assisted cough; MD: mean difference; ME: mechanical exsufflation; MI: mechanical insufflation; MI‐E: mechanical insufflation/exsufflation; min: minute; n: number of participants; NS: not significant; SD: standard deviation; VAS: visual analogue scale.
aBaseline value – not a randomly assigned control.
bUsing raw first‐period data provided by the author on request.